Robert Person
Family Medicine · Easley, SCNPI 1740294305
Payments from drug & device makers
Across 556 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$949
- AbbVie$851
- Novo Nordisk$830
- Lilly USA, LLC$631
- Johnson & Johnson$618
- plus $4K from 29 others
What the payments were for
- Food & beverage$8,815100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 70 | $1,132 |
| GSK | 61 | $949 |
| AbbVie(2 entities) | 57 | $851 |
| Novo Nordisk | 52 | $830 |
| Lilly USA, LLC | 41 | $631 |
| Johnson & Johnson | 46 | $618 |
| Boehringer Ingelheim | 26 | $432 |
| Amgen | 27 | $423 |
| Pfizer | 27 | $412 |
| Sanofi-aventis U.S. LLC | 24 | $353 |
| Novartis | 20 | $304 |
| Nestle Healthcare Nutrition Inc. | 14 | $219 |
| Bayer | 12 | $177 |
| Exact Sciences | 8 | $132 |
| Paratek Pharmaceuticals, Inc. | 6 | $130 |
| Merck | 8 | $109 |
| Dexcom, Inc. | 8 | $109 |
| Stryker | 1 | $102 |
| Boston Scientific | 4 | $97 |
| Abbott | 5 | $85 |
| Daiichi Sankyo Inc. | 4 | $85 |
| Esperion Therapeutics, Inc. | 5 | $83 |
| Astellas Pharma US Inc | 4 | $79 |
| Xeris Pharmaceuticals, Inc. | 4 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $67 |
| Eisai Inc. | 4 | $65 |
| Mylan Specialty L.p. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Edwards Lifesciences | 1 | $41 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Lucid Diagnostics Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $20 |
| Smith+Nephew | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$136
- SPRAVATO$132
- SPY-PHI SYSTEM$102
How this compares
$8,815 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 113 | $93,755 |
| OzempicSemaglutide | 69 | $69,926 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 65 | $59,556 |
| FarxigaDapagliflozin Propanediol | 63 | $48,522 |
| XareltoRivaroxaban | 67 | $48,102 |
| JanuviaSitagliptin Phosphate | 28 | $32,743 |
| MounjaroTirzepatide | 25 | $28,005 |
| MyrbetriqMirabegron | 29 | $26,547 |
| EliquisApixaban | 15 | $23,875 |
| RybelsusSemaglutide | 21 | $23,206 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 25 | $17,718 |
| EntrestoSacubitril/Valsartan | 15 | $15,309 |
| TrulicityDulaglutide | 15 | $13,926 |
| Repatha SureclickEvolocumab | 21 | $13,732 |
| KerendiaFinerenone | 17 | $12,392 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Combivent Respimat | $432 | $111,473138 claims |
| Novo NordiskOzempic, Rybelsus | $830 | $93,13390 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $949 | $69,17581 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,132 | $64,07293 claims |
| Johnson & JohnsonXarelto | $618 | $48,10267 claims |
| Lilly USA, LLCMounjaro, Trulicity | $631 | $41,93040 claims |
| MerckJanuvia | $109 | $32,74328 claims |
| Astellas Pharma US IncMyrbetriq | $79 | $26,54729 claims |
| PfizerEliquis | $412 | $23,87515 claims |
| NovartisEntresto | $304 | $15,30915 claims |
| BayerKerendia | $177 | $12,39217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Easley
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.